The Cannabis Boomer's Daily Feed for December 11, 2025
Alleged Fraud in Massachusetts Cannabis Industry Raises Concerns
A local law enforcement group has raised alarms about the reliability of cannabis products in Massachusetts. Alleged inflated THC percentages and the failure of a testing lab to report the presence of yeast and mold raise questions about the accuracy of testing and the oversight of the industry by state regulators. Addressing these concerns will be crucial to ensuring consumer trust and public safety as the industry continues to grow.
Ohio Lawmakers Shake Up Marijuana and Hemp Regulations
Ohio lawmakers have passed a bill that will significantly impact the state's cannabis industry. The new legislation places Ohio's adult-use marijuana program under the Division of Cannabis Control, aligns the regulation of edibles and gummies with other forms of marijuana consumption, and restricts the sale of intoxicating hemp products to licensed dispensaries. These changes aim to provide better oversight and control over the cannabis market in Ohio.
Cannabis Use and Eating Pathology
A study identified distinct subgroups of recreational cannabis users and found that all profiles reported more binge-eating symptoms while under the influence of cannabis. The "High-Risk Coping Users, Strong Eating Changes" profile reported the most severe sober binge eating, eating disorder, and emotion regulation difficulties. The findings highlight the need for screening and intervention tools to determine eating disorder risk among cannabis users.
PET Imaging of the Endocannabinoid System in Psychiatric Disorders
Positron emission tomography (PET) imaging has enabled the in vivo exploration of the endocannabinoid system (ECS) in various psychiatric disorders, providing insights into the pathophysiological mechanisms and informing clinical management strategies. PET imaging has the potential to guide the development of novel therapeutic interventions targeting the ECS and to inform personalized treatment approaches for psychiatric patients.
Safe Use of CBD in Patients with Refractory Epilepsy
A review article discusses the practical considerations for the safe use of CBD in patients with drug-resistant epilepsy, summarizing the current evidence on the pharmacokinetics and safety profile of CBD, and providing guidance on dosing, titration, and concomitant use of other anti-seizure medications. The review highlights the need for careful patient selection, close clinical monitoring, and an individualized approach to CBD treatment in this patient population.
#CannabisIndustry #Regulation #EatingDisorders #PsychiatricDisorders #Epilepsy #CBD
